# Phase 1 Study of OTS167 in Patients With Solid Tumors

> **NCT01910545** · PHASE1 · COMPLETED · sponsor: **OncoTherapy Science, Inc.** · enrollment: 32 (actual)

## Conditions studied

- Solid Tumors
- Metastatic Tumors

## Interventions

- **DRUG:** OTS167IV

## Key facts

- **NCT ID:** NCT01910545
- **Lead sponsor:** OncoTherapy Science, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-08-23
- **Primary completion:** 2016-04-11
- **Final completion:** 2016-05-04
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2017-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01910545

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01910545, "Phase 1 Study of OTS167 in Patients With Solid Tumors". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01910545. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*